abstract
Future of Health Summit 2024

How Pharmaceutical Supply Chain Advancements Are Meeting the Moment and Beyond

-

The health-care supply chain has undergone significant transformations driven by evolving health-care demands, technological advancements, and regulatory shifts. Patient-centric approaches, upskilled workers, and enhanced industry-wide collaboration are strengthening end-to-end resilience, enabling the fulfillment of patient needs on an unprecedented scale. This session will explore what may help accelerate transparency, communication, logistics and security to overcoming access challenges in under-resourced communities. The panelists will also discuss what may be achieved through digital enablement, industry readiness for the upcoming implementation of the Drug Supply Chain Security Act and potential actions to mitigate labor and drug shortages.

    Moderator

    Image

    Sarah Karlin-Smith

    Senior Writer, Pink Sheet (Citeline Regulatory)

    Speakers

    Image

    Laura Bray

    Chief Change Maker, Angels for Change
    Image

    Shamiram Feinglass

    Managing Director, Manatt Health Strategies, Manatt, Phelps and Phillips, LLP
    Image

    Kirk Kaminsky

    President, U.S. Pharmaceutical, McKesson
    Image

    Vimala Raghavendran

    Vice President, Digital and Innovation, US Pharmacopeia